We hereby inform you that on 17th November''2025 the Various department of Asarfi Hospital have been granted accreditation by the National Board of Examination in Medical Sciences (NBEMS).
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.8 pts more than Nifty Microcap 250 and 7.4 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
On 17th November 2025, Asarfi Hospital received accreditation from the National Board of Examinations in Medical Sciences (NBEMS) for five of its departments. The accreditation covers two DNB courses — Family Medicine (4 seats, 3 years) and General Surgery (2 seats, 3 years) — along with three NBEMS Diploma programmes in Radiology (DMRD), Obstetrics & Gynaecology, and Paediatrics, each with 2 seats and a 2-year duration, taking the total to 12 training seats. This allows the hospital to run postgraduate medical training programmes officially recognised by NBEMS. The accreditation agreement has been issued and uploaded on the NBEMS portal, and the update has also been shared on the company's website.
This is a positive operational milestone — it strengthens Asarfi Hospital's credentials as a teaching hospital, opens a new revenue stream from postgraduate trainee fees, and may attract more patients and doctors. The development is incrementally positive for the company's long-term growth profile, though the financial impact is likely modest in the near term.